Tirzepatide in obesitythe surmount clinical study program The GLP-1RA liraglutide has been approved for the pharmacological treatment of obesity and various other GLP-1RA may be approved in the future for this indication as well (3941, 81)
This article outlines best-practice subcutaneous injection technique covering site selection, rotation, skin preparation, sites to avoid, storage, and sharps disposal to support safe participation in retatrutide clinical trials
Patients also commonly experience steady and sustained weight loss, improved energy levels, and better overall metabolic health
I think we need to consider that the efficacy of these medications is decreased if they are not taken consistently, and I am curious to see how they perform in real life, Levy said
According to the World Health Organization (WHO), the global prevalence of obesity has nearly tripled since 1975
Future developments affecting us may not be those that we have anticipated